Changes in Intravenous Anesthetic Drug Dosage in Insomnia Patients Undergoing Digestive Endoscopy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-64
SponsorBeijing Tiantan Hospital
About this trial
To compare the dosage requirement of intravenous anesthetics during digestive endoscopy between patients with insomnia and those with normal sleep pattern.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age of 18 - 64 years;
ASA physical status of I - II;
BMI of 15 - 30;
Scheduled for digestive endoscopy under intravenous anesthesia;
Disqualifiers
1. Associated with any neurological disease; 2. Daily alcohol consumption; 3. Any contraindication to intravenous anesthetic drug, such as hypotension or shock; 4. History of allergy to any drug used in the study; 5. Pregnancy or breastfeeding; 6. Patients with sleep apnea syndrome; 7. acute upper respiratory infection; 8. Patients with psychological diseases who report suicidal thoughts; 9. Patients who need to work or take care of children/elderly people frequently at night.
Trial population
Patients with insomnia and patients with normal sleep patterns
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
No interventions, it is a observational study
Other interventionNo interventions, this study is to compare the dosage requirement of intravenous anesthetic drug during digestive endoscopy between insomnia group and normal sleep group.
Treatment groups
3,360 Participants
are divided into 2 treatment groupsGroup A: Insomnia group1 intervention
Group B: Normal sleep group1 intervention
Trial outcomes
Primary outcomes
1
The total consumption of intravenous anesthetic drug
The total consumption of intravenous anesthetic drug for digestive endoscopy. It includes the total amount of intravenous anesthesia drugs required by the patient for the entire process of digestive endoscopy.
Time frame
Up to 1 daySecondary outcomes
1
The dosage of intravenous anesthetic drug for successful insertion of digestive endoscope
The dosage of intravenous anesthetic drug for successful insertion of digestive endoscope
Time frame
1 day2
The occurrence of the respiratory and cardiovascular adverse events
The occurrence of the respiratory and cardiovascular adverse events such as hypoxemia, hypotension, hypertension, arrhythmia
Time frame
The day for patients undergoing digestive endoscopy and 24 hours after the digestive endoscopy3
The occurrence of the other adverse events
The occurrence of the other adverse events such as dizziness, agitation, nausea, vomiting and psychiatric symptom
Time frame
The day for patients undergoing digestive endoscopy and 24 hours after the digestive endoscopy4
The incidence of intraoperative recall or awareness
The patient is conscious after anesthesia
Time frame
The day for patients undergoing digestive endoscopy and 24 hours after the digestive endoscopySponsors and contacts
Click on the lead sponsor to view all of their trials.
Beijing Tiantan Hospital
Lead sponsor
Daxing Teaching Hospital, Capital Medical University
Collaborator
Hebei Medical University Third Hospital
Collaborator
Hengshui People's Hospital
Collaborator
Source ClinicalTrials.gov